-
EP2662390
European procedure
Extract from the Register of European Patents
EP About this file: EP2662390
| EP2662390 - Interferon alpha receptor 1 antibodies and their uses [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 08.06.2018 Database last updated on 26.06.2024 | |
| Former | The patent has been granted Status updated on 30.06.2017 | ||
| Former | Grant of patent is intended Status updated on 19.02.2017 | Most recent event Tooltip | 08.06.2018 | No opposition filed within time limit | published on 11.07.2018 [2018/28] | Applicant(s) | For all designated states E. R. Squibb & Sons, L.L.C. Route 206 and Province Line Road Princeton, NJ 08540 / US | [2015/03] |
| Former [2013/46] | For all designated states Medarex, L.L.C. Route 206 and Province Line Road Princeton, NJ 08540 / US | Inventor(s) | 01 /
Cardarelli, Josephine M. 126 Leslie Drive San Carlos, CA 94070 / US | 02 /
Witte, Alison 6325 E Evans Creek Road Rogue River, OR 97537-9605 / US | 03 /
Srinivasan, Mohan 1044 Arlington Lane San Jose, CA 95129 / US | [2013/46] | Representative(s) | Reitstötter Kinzebach Patentanwälte Sternwartstraße 4 81679 München / DE | [N/P] |
| Former [2017/31] | Reitstötter Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | ||
| Former [2013/46] | Reitstötter - Kinzebach Patentanwälte Sternwartstrasse 4 81679 München / DE | Application number, filing date | 13162333.2 | 20.06.2005 | [2013/46] | Priority number, date | US20040581747P | 21.06.2004 Original published format: US 581747 P | [2013/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2662390 | Date: | 13.11.2013 | Language: | EN | [2013/46] | Type: | B1 Patent specification | No.: | EP2662390 | Date: | 02.08.2017 | Language: | EN | [2017/31] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 14.10.2013 | Classification | IPC: | C07K16/28 | [2013/46] | CPC: |
C07K16/2866 (EP,KR,RU,US);
A61K47/6801 (RU);
A61P1/00 (EP);
A61P1/04 (EP);
A61P13/12 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P17/16 (EP);
A61P19/02 (EP);
A61P19/04 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
A61P5/14 (EP);
A61P5/48 (EP);
C07K2317/21 (EP,KR,US);
C07K2317/31 (KR,US);
C07K2317/56 (EP,KR,US);
C07K2317/565 (EP,KR,US);
C07K2317/74 (EP,KR,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2017/31] |
| Former [2013/46] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | Interferon-Alpha-Rezeptor-1-Antikörper und deren Verwendungen | [2013/46] | English: | Interferon alpha receptor 1 antibodies and their uses | [2013/46] | French: | Anticorps du récepteur 1 de l'interféron alpha et leurs utilisations | [2013/46] | Examination procedure | 13.05.2014 | Examination requested [2014/26] | 04.12.2015 | Despatch of a communication from the examining division (Time limit: M04) | 11.04.2016 | Reply to a communication from the examining division | 30.01.2017 | Cancellation of oral proceeding that was planned for 31.01.2017 | 31.01.2017 | Date of oral proceedings (cancelled) | 20.02.2017 | Communication of intention to grant the patent | 19.06.2017 | Fee for grant paid | 19.06.2017 | Fee for publishing/printing paid | 19.06.2017 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP05787743.3 / EP1781705 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050787743) is 25.03.2011 | Opposition(s) | 03.05.2018 | No opposition filed within time limit [2018/28] | Fees paid | Renewal fee | 04.04.2013 | Renewal fee patent year 03 | 04.04.2013 | Renewal fee patent year 04 | 04.04.2013 | Renewal fee patent year 05 | 04.04.2013 | Renewal fee patent year 06 | 04.04.2013 | Renewal fee patent year 07 | 04.04.2013 | Renewal fee patent year 08 | 10.06.2013 | Renewal fee patent year 09 | 12.06.2014 | Renewal fee patent year 10 | 10.06.2015 | Renewal fee patent year 11 | 10.06.2016 | Renewal fee patent year 12 | 16.06.2017 | Renewal fee patent year 13 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]US6713609 (CHUNTHARAPAI ANAN [US], et al) [X] 1-4,6-14,16-18 * columns 49,50,53; table 2 * [I] 15; | [XP]WO2004094473 (MEDAREX INC [US], et al) [XP] 1-4,6-14,16-18 * page 36; example 1 *; | [XP]WO2004093908 (MEDAREX INC [US], et al) [XP] 1-4,6-14,16-18 * page 32 - page 37; claims 1-8 *; | [X] - GOLDMAN L A ET AL, "Characterization of antihuman IFNAR-1 monoclonal antibodies: Epitope localization and functional analysis", JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, MARY ANN LIEBERT, NEW YORK, NY, US, (19990101), vol. 19, no. 1, ISSN 1079-9907, pages 15 - 26, XP002307845 [X] 1-4,6-14,16-18 * abstract * | [X] - BENOIT P ET AL, "A MONOCLONAL ANTIBODY TO RECOMBINANT HUMAN IFN-ALPHA RECEPTOR INHIBITS BIOLOGIC ACTIVITY OF SEVERAL SPECIES OF HUMAN IFN-ALPHA, IFN-BETA, AND IFN-ONIEGA. DETECTION OF HETEROGENEITY OF THE CELLULAR TYPE I IFN RECEPTOR", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, (19930201), vol. 150, no. 3, ISSN 0022-1767, pages 707 - 716, XP002025928 [X] 1-4,6-14,16-18 * page 709, column r, paragraph penultimate - page 710, column l, paragraph 3 * | [A] - WINTER G ET AL, "ANTIBODY-BASED THERAPY, HUMANIZED ANTIBODIES", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER, HAYWARTH, GB, (19930501), vol. 14, no. 5, doi:10.1016/0165-6147(93)90197-R, ISSN 0165-6147, pages 139 - 143, XP001205172 [A] 1-18 * the whole document * DOI: http://dx.doi.org/10.1016/0165-6147(93)90197-R | Examination | - JI LU ET AL., "Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: The role of domains 1 and 2", THE JOURNAL OF IMMUNOLOGY, (1998), vol. 160, pages 1782 - 1788, XP055018579 | - SIGRID BEIBOER ET AL., "Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent", J. MOL. BIOL., (2000), vol. 296, pages 833 - 849, XP000944326 DOI: http://dx.doi.org/10.1006/jmbi.2000.3512 | - A. KLIMKA ET AL, "Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning", BRITISH JOURNAL OF CANCER, (2000), vol. 83, no. 2, pages 252 - 260, XP001021661 DOI: http://dx.doi.org/10.1054/bjoc.2000.1226 | - LI PENG ET AL, "Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-alpha receptor 1 antibody", MABS, (201503), vol. 7, no. 2, pages 428 - 439 | by applicant | US4399216 | US4439196 | US4447233 | US4447224 | US4475196 | US4486194 | US4487603 | US4522811 | EP0154316 | US4596556 | US4634665 | WO8704462 | WO8800052 | US4790824 | WO8901036 | US4816567 | EP0338841 | US4881175 | US4941880 | US4946778 | US4954617 | EP0401384 | US5013653 | US5064413 | US5091513 | WO9203918 | US5132405 | US5179017 | WO9312227 | US5223409 | US5225539 | US5258498 | US5260203 | WO9410332 | US5312335 | WO9425585 | US5374548 | WO9429351 | US5383851 | US5399163 | US5399331 | US5403484 | US5416016 | US5427908 | US5455030 | US5476996 | US5476786 | US5482858 | US5530101 | US5545806 | US5545807 | US5569825 | US5571698 | US5580717 | US5585089 | WO9713852 | US5624821 | US5625126 | US5625825 | US5633425 | US5648260 | US5661016 | US5677425 | US5693762 | US5698767 | US5714350 | WO9824884 | US5770429 | US5789650 | US5814318 | US5869046 | US5874299 | US5877397 | US5885793 | US5888511 | US5939598 | WO9945962 | US5969108 | WO9954342 | US6075181 | WO0042072 | US6114598 | US6121022 | US6150584 | US6162963 | US6165745 | US6172197 | US6180370 | WO0109187 | US6194551 | WO0114424 | US6277375 | EP1176195 | US6350861 | WO0243478 | US2002160974 | WO02092780 | US6521404 | US6544731 | US6555313 | WO03035835 | US6582915 | US6593081 | US2003153043 | WO03074679 | - HARDY ET AL., BLOOD, (2001), vol. 97, page 473 | - CUTRONE; LANGER, J. BIOL. CHEM, (2001), vol. 276, page 17140 | - WEISSMANN; WEBER, PROG. NUCL. ACID RES. MOL. BIOL., (1986), vol. 33, pages 251 - 300 | - STREULI ET AL., PROC. NATL. ACAD. SCI. USA, (1981), vol. 78, page 2848 | - AGNET M. ET AL., Interferon 5 th ed., ACADEMIC PRESS, (1983), pages 1 - 22 | - UZE, CELL, (1990), vol. 60, page 225 | - NOVICK ET AL., CELL, (1994), vol. 77, page 391 | - COOK ET AL., J. BIOL. CHEM., (1996), vol. 271, page 13448 | - LEWERENZ ET AL., J. MOL. BIOL., (1998), vol. 282, page 585 | - HALLER ET AL., J. EXP. MED., (1981), vol. 154, page 199 | - LINDENMANN ET AL., METHODS ENZYMOL., (1981), vol. 78, page 181 | - BRINKMANN ET AL., J. EXP. MED., (1993), vol. 178, page 1655 | - FINKELMAN ET AL., J. EXP. MED., (1991), vol. 174, page 1179 | - SANTINI ET AL., J. EXP. MED., (2000), vol. 191, page 1777 | - TOUGH ET AL., SCIENCE, (1996), vol. 272, page 1947 | - LUFT ET AL., J. IMMUNOL., (1998), vol. 161, page 1947 | - LUFT ET AL., INT. IMMUNOL., (2002), vol. 14, page 367 | - RADVANYI ET AL., SCAND. J. IMMUNOL., (1999), vol. 50, page 499 | - FOULIS ET AL., LANCET, (1987), vol. 2, page 1423 | - HOOKS ET AL., ARTHRITIS RHEUM., (1982), vol. 25, page 396 | - HERTZOG ET AL., CLIN. IMMUNOL. IMMUNOPATHOL., (1988), vol. 48, page 192 | - HOPKINS; MEAGER, CLIN. EXP. IMMUNOL., (1988), vol. 73, page 88 | - ARVIN; MILLER, ARTHRITIS RHEUM., (1984), vol. 27, page 582 | - WARD ET AL., NATURE, (1989), vol. 341, pages 544 - 546 | - BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426 | - HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 5879 - 5883 | - E. MEYERS; W. MILLER, COMPUT. APPL. BIOSCI., (1988), vol. 4, pages 11 - 17 | - NEEDLEMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, pages 444 - 453 | - ALTSCHUL ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 10 | - ALTSCHUL ET AL., NUCLEIC ACIDS RES., (1997), vol. 25, no. 17, pages 3389 - 3402 | - RIECHMANN, L ET AL., NATURE, (1998), vol. 332, pages 323 - 327 | - JONES, P. ET AL., NATURE, (1986), vol. 321, pages 522 - 525 | - QUEEN, C. ET AL., PROC. NATL. ACAD. SEE. US.A., (1989), vol. 86, pages 10029 - 10033 | - TOMLINSON, I. M. ET AL., "The Repertoire of Human Germline VH Sequences Reveals about Fifty Groups of VH Segments with Different Hypervariable Loops", J. MOL. BIOL., (1992), vol. 227, pages 776 - 798 | - COX, J. P. L. ET AL., "A Directory of Human Germ-line VH Segments Reveals a Strong Bias in their Usage", EUR. J. IMMUNOL., (1994), vol. 24, pages 827 - 836 | - SHIELDS, R.L. ET AL., J. BIOL. CHEM., (2001), vol. 276, pages 6591 - 6604 | - SHIELDS, R.L. ET AL., J. BIOL. CHEM., (2002), vol. 277, pages 26733 - 26740 | - UMANA ET AL., NAT. BIOTECH., (1999), vol. 17, pages 176 - 180 | - MCCAFFERTY ET AL., NATURE, (1990), vol. 348, pages 552 - 554 | - KOHLER; MILSTEIN, NATURE, (1975), vol. 256, page 495 | - LONBERG ET AL., NATURE, (1994), vol. 368, no. 6474, pages 856 - 859 | - LONBERG, N., Handbook of Experimental Pharmacology, (1994), vol. 113, pages 49 - 101 | - LONBERG, N.; HUSZAR, D., INTERN. REV. IMMUNOL., (1995), vol. 13, pages 65 - 93 | - HARDING, F.; LONBERG, N., ANN. N.Y. ACAD. SCI., (1995), vol. 764, pages 536 - 546 | - TAYLOR, L. ET AL., NUCLEIC ACIDS RESEARCH, (1992), vol. 20, pages 6287 - 6295 | - CHEN, J. ET AL., INTERNATIONAL IMMUNOLOGY, (1993), vol. 5, pages 647 - 656 | - TUAILLON ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 3720 - 3724 | - CHOI ET AL., NATURE GENETICS, (1993), vol. 4, pages 117 - 123 | - CHEN, J. ET AL., EMBO J., (1993), vol. 12, pages 821 - 830 | - TUAILLON ET AL., J IMMUNOL., (1994), vol. 152, pages 2912 - 2920 | - TAYLOR, L. ET AL., INTERNATIONAL IMMUNOLOGY, (1994), vol. 6, pages 579 - 591 | - FISHWILD, D. ET AL., NATURE BIOTECHNOLOGY, (1996), vol. 14, pages 845 - 851 | - TOMIZUKA ET AL., PROC. NATL. ACAD. SCI. USA, (2000), vol. 97, pages 722 - 727 | - KUROIWA ET AL., NATURE BIOTECHNOLOGY, (2002), vol. 20, pages 889 - 894 | - LONBERG, N. ET AL., NATURE, (1994), vol. 368, no. 6474, pages 856 - 859 | - MORRISON, S., SCIENCE, (1985), vol. 229, page 1202 | - GOEDDEL, Gene Expression Technology. Methods in Enzymology, ACADEMIC PRESS, (1990), vol. 185 | - TAKEBE, Y. ET AL., MOL. CELL. BIOL., (1988), vol. 8, pages 466 - 472 | - BOSS, M. A.; WOOD, C. R., IMMUNOLOGY TODAY, (1985), vol. 6, pages 12 - 13 | - URLAUB; CHASIN, PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, pages 4216 - 4220 | - R. J. KAUFINAN; P. A. SHARP, MOL. BIOL., (1982), vol. 159, pages 601 - 621 | - SAITO, G. ET AL., ADV. DRUG DELIV. REV., (2003), vol. 55, pages 199 - 215 | - TRAIL, P.A. ET AL., CANCER IMMUNOL. IMMUNOTHER., (2003), vol. 52, pages 328 - 337 | - PAYNE, G., CANCER CELL, (2003), vol. 3, pages 207 - 212 | - ALLEN, T.M., NAT. REV. CANCER, (2002), vol. 2, pages 750 - 763 | - PASTAN, 1.; KREITMAN, R. J., CURR. OPIN. INVESTIG. DRUGS, (2002), vol. 3, pages 1089 - 1091 | - SENTER, P.D.; SPRINGER, C.J., ADV. DRUG DELIV. REV., (2001), vol. 53, pages 247 - 264 | - "Monoclonal Antibodies For Immunotargeting Of Drugs In Cancer Therapy", AMON ET AL., Monoclonal Antibodies And Cancer Therapy, ALAN R. LISS, INC., (1985), pages 243 - 56 | - "Antibodies For Drug Delivery", HELLSTROM ET AL., Controlled Drug Delivery, MARCEL DEKKER, INC., (1987), pages 623 - 53 | - "Antibody Carriers Of Cytotoxic Agents In Cancer Therapy: A Review", THORPE ET AL., Monoclonal Antibodies '84: Biological And Clinical Applications, (1985), pages 475 - 506 | - "Analysis, Results, And Future Prospective Of The Therapeutic Use Of Radiolabeled Antibody In Cancer Therapy", Monoclonal Antibodies For Cancer Detection And Therapy, ACADEMIC PRESS, (1985), pages 303 - 16 | - THORPE, "The Preparation And Cytotoxic Properties Of Antibody-Toxin Conjugates", IMMUNOL. REV., (1982), vol. 62, pages 119 - 58 | - GRAZIANO, R.F. ET AL., J. IMMUNOL, (1995), vol. 155, no. 10, pages 4996 - 5002 | - MORTON, H.C. ET AL., CRITICAL REVIEWS IN IMMUNOLOGY, (1996), vol. 16, pages 423 - 440 | - MONTEIRO, R.C. ET AL., J. IMMUNOL., (1992), vol. 148, page 1764 | - KARPOVSKY ET AL., J. EXP. MED., (1984), vol. 160, page 1686 | - LIU, MA ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, page 8648 | - PAULUS, BEHRING INS. MITT., (1985), vol. 78, pages 118 - 132 | - BRENNAN ET AL., SCIENCE, (1985), vol. 229, pages 81 - 83 | - GLENNIE ET AL., J. IMMUNOL., (1987), vol. 139, pages 2367 - 2375 | - BERGE, S.M. ET AL., J. PHARM. SCI., (1977), vol. 66, pages 1 - 19 | - V.V. RANADE, J. CLIN. PHARMACOL., (1989), vol. 29, page 685 | - UMEZAWA ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1988), vol. 153, page 1038 | - P.G. BLOEMAN ET AL., FEBS LETT., (1995), vol. 357, page 140 | - M. OWAIS ET AL., ANTIMICROB. AGENTS CHEMOTHER., (1995), vol. 39, page 180 | - BRISCOE ET AL., AM. J. PHYSIOL., (1995), vol. 1233, page 134 | - SCHREIER ET AL., J. BIOL. CHEM., (1994), vol. 269, page 9090 | - K. KEINANEN; M.L. LAUKKANEN, FEBS LETT., (1994), vol. 346, page 123 | - J.J. KILLION; I.J. FIDLER, IMMUNOMETHODS, (1994), vol. 4, page 273 | - KIM ET AL., CLIN. EXP. IMMUNOL., (1987), vol. 70, pages 562 - 569 | - GARCIA-PORRUA ET AL., CLIN. EXP. RHEUMATOL., (1998), vol. 16, pages 107 - 108 | - FOULIS ET AL., LANCET, (1987), vol. 2, pages 1423 - 1427 | - WAGURI ET AL., DIABETES RES. CLIN. PRACT., (1994), vol. 23, pages 33 - 36 | - MONZANI ET AL., CLIN. EXP. MED., (2004), vol. 3, pages 199 - 210 | - PRUMMEL; LAURBERG, THYROID, (2003), vol. 13, pages 547 - 551 | - HERTZOG ET AL., CLIN. IMMUNOL. IMMUNOPATH., (1988), vol. 48, page 192 | - DESTEFANO ET AL., J. INFEC. DISEASE, (1982), vol. 146, page 451 | - VADHAN-RAJ ET AL., CANCER RES., (1986), vol. 46, page 417 | - TOVEY ET AL., J. LEUKOC. BIOL., (1996), vol. 59, pages 512 - 517 | - BENIZRI ET AL., J. INTERFERON CYTOKINE RES., (1998), vol. 18, pages 273 - 284 | - CHEN ET AL., EMBO J., (1993), vol. 12, pages 811 - 820 | - FISHWILD ET AL., NATURE BIOTECHNOLOGY, (1996), vol. 14, pages 845 - 851 | US20030465155 | US20030465058 |